Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 23, 2016 - Issue 1
221
Views
6
CrossRef citations to date
0
Altmetric
Original Article

The polyphenol (−)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity

, , , , , , , , , & show all
Pages 17-25 | Received 09 Mar 2015, Accepted 22 Oct 2015, Published online: 24 Dec 2015
 

Abstract

Introduction: Apolipoprotein A-I (apoA-I) amyloidosis is either a non-hereditary form with deposits of wild-type apoA-I proteins in atherosclerotic plaques or a hereditary form with progressive accumulation of mutant apoA-I proteins in different tissues. Several small polyphenolic molecules reportedly inhibited formation of fibrillar assemblies of some amyloidogenic proteins and their cytotoxicity, but small molecules that inhibit apoA-I fibril formation have never been reported.

Methods: Our methods included a thioflavin-T-binding assay, atomic force microscopy and dot blot and cell-based assays.

Results: We showed that (−)-epigallocatechin-3-gallate (EGCG), a tea-derived flavanol, inhibited in vitro fibril formation and disaggregated fibrils preformed by the N-terminal 1–83 fragments of wild-type (WT) apoA-I and the G26R point mutation of apoA-I (apoA-IIowa). We eliminated a common structure recognized by the anti-amyloid antibody OC by incubating apoA-IIowa with EGCG or treating apoA-IIowa fibrils with EGCG, which supported the above observation. In addition, EGCG rescued human embryonic kidney 293 cells from cytotoxicity and attenuated production of reactive oxygen species, which were induced by apoA-IIowa fibrils.

Conclusions: Our results support the concept that EGCG inhibits amyloid fibril formation of various amyloidogenic proteins. Thus, EGCG may be a candidate for providing a structure to develop de novo inhibitors for amyloidosis treatment.

Acknowledgements

The authors would like to thank the Support Center for Advanced Medical Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School.

Declaration of interest

The authors report no conflicts of interest. This work was partly supported by Grant-in-Aid for Scientific Research B-25293006 (to H. S.), Grant-in-Aid for Scientific Research C-23590448 and Grant-in-Aid for Challenging Exploratory Research 26670190 (to N. S.) and Grant-in-Aid for Young Scientists B-15K19488 (to K. N.) from the Japan Society for the Promotion of Science.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.